Neonatal Death
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
2 programsCHV-NEON/A1 trial
Interactive two-way SMS dialogueN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesCHV-NEO
Human BioSciencesInteractive two-way SMS dialogue
Clinical Trials (2)
Total enrollment: 8,020 patients across 2 trials
CHV-NEO: Community-based Digital Communication to Support Neonatal Health
Start: Jan 2024Est. completion: Jun 20263,000 patients
N/ARecruiting
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
Start: Sep 2020Est. completion: Feb 20235,020 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 8,020 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.